| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 2.82 MB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
A nĆvel mundial, verifica-se um aumento da população idosa, devido Ć crescente esperanƧa de vida e Ć diminuição da taxa de natalidade. Associada Ć idade avanƧada, diversas alteraƧƵes, tanto a nĆvel fisiológico, como psicológico e social ocorrem no idoso.
As modificaƧƵes derivadas do envelhecimento contribuem para o desenvolvimento e aparecimento de comorbilidades, bem como para o aumento do nĆŗmero de medicamentos consumidos. Em virtude destas alteraƧƵes, o doente geriĆ”trico apresenta-se como um indivĆduo complexo. A resposta farmacocinĆ©tica/farmacodinĆ¢mica dos fĆ”rmacos pode-se encontrar alterada, contribuindo para um risco superior de reaƧƵes adversas e interaƧƵes medicamentosas quando comparada com a população mais jovem. Adicionalmente, a necessidade de realizar antibioterapia Ć© superior devido Ć maior suscetibilidade a infeƧƵes nesta faixa etĆ”ria.
A instituição da terapêutica antibiótica no idoso é um processo complexo. O diagnóstico, a presença de múltiplas patologias e diversas medicações, as alterações naturais do envelhecimento e o maior risco de desenvolvimento de resistências são fatores que contribuem para aumentar a dificuldade no processo de decisão. Assim, a gestão da terapêutica antibiótica no idoso deve contemplar inúmeros fatores, baseando-se no perfil individual de cada doente, garantindo a efetividade e a segurança do tratamento, de modo a prevenir futuras complicações.
Globally, the elderly population is increasing due to the rising life expectancy and declining birth rates. Associated with advanced age, several changes, both physiological, psychological and social occur in the elderly. Modifications derived from aging contribute to the development of comorbidities, as well as to the increase in the number of drugs consumed. Due to these changes, the geriatric patient is presented as a complex individual. The pharmacokinetic/pharmacodynamic response of drugs may be altered, contributing to a higher risk of adverse reactions and drug interactions compared to the younger population. Additionally, the need for antibiotic therapy is higher due to greater susceptibility to infections in this age group. The institution of antibiotic therapy in the elderly is a challenging process due to the difficulty in diagnosis, the presence of multiple pathologies and polipharmacy, the natural changes in aging and the increased risk of resistance development. Thus, the management of antibiotic therapy in the elderly should consider multiple factors, based on the individual profile of each patient, ensuring the effectiveness and safety of treatment, in order to prevent future complications.
Globally, the elderly population is increasing due to the rising life expectancy and declining birth rates. Associated with advanced age, several changes, both physiological, psychological and social occur in the elderly. Modifications derived from aging contribute to the development of comorbidities, as well as to the increase in the number of drugs consumed. Due to these changes, the geriatric patient is presented as a complex individual. The pharmacokinetic/pharmacodynamic response of drugs may be altered, contributing to a higher risk of adverse reactions and drug interactions compared to the younger population. Additionally, the need for antibiotic therapy is higher due to greater susceptibility to infections in this age group. The institution of antibiotic therapy in the elderly is a challenging process due to the difficulty in diagnosis, the presence of multiple pathologies and polipharmacy, the natural changes in aging and the increased risk of resistance development. Thus, the management of antibiotic therapy in the elderly should consider multiple factors, based on the individual profile of each patient, ensuring the effectiveness and safety of treatment, in order to prevent future complications.
Description
Dissertação para obtenção do grau de Mestre no Instituto UniversitÔrio Egas Moniz
Keywords
Envelhecimento Antibioterapia Idoso InfeƧƵes bacterianas
